Purpose/Background: Antipsychotic drugs are well established to alter circulating prolactin levels by blocking dopamine D 2 receptors in the pituitary. Prolactin activates many genes important in the development of breast cancer. Prior studies have found an association with antipsychotic use and risk of breast cancer.